Skip to main content
NIH funding notice RFA-DK-15-022

Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)

Closed on November 18, 2015.

Posted
July 24, 2015
Close date
November 18, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
5
4 new, 1 renewal
Median first-year cost
$224,825
$1,716,749 in all
Institutions
5
5 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. CAPILLARY BIOMEDICAL, INC.1
  2. INTEGRATED MEDICAL SENSORS1
  3. PROFUSA, INC.1
  4. SFC FLUIDICS, LLC1
  5. THERMALIN DIABETES, LLC1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-2 (M4))5
5 awards under RFA-DK-15-022 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2016Long-term non-enzymatic glucose sensor for an artificial pancreas2R44DK101000-02Wisniewski, Natalie AnnPROFUSA, INC., CAFirst-year cost $966,527Study section ZDK1
FY2016Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor1R43DK110972-01Payne, ForrestSFC FLUIDICS, LLC, ARFirst-year cost $225,000Study section ZDK1
FY2016A Low-cost microscale implantable wireless glucose sensor for diabetes management1R43DK111001-01Antwerp, William VanHonarvar Nazari, MeisamINTEGRATED MEDICAL SENSORS, CAFirst-year cost $224,825Study section ZDK1
FY2016Multi-Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On-Off Pharmacodynamic Actions1R43DK110969-01Strasma, Paul JCAPILLARY BIOMEDICAL, INC., CAFirst-year cost $223,896Study section ZDK1
FY2016Enabling implantable artificial pancreas pumps with heat-stable, ultra-rapid insulin1R43DK111003-01Frank, Bruce HillTHERMALIN DIABETES, LLC, OHFirst-year cost $76,501Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-15-022: Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44) | ScienceDex | ConductScience